Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
62.90
-0.60 (-0.94%)
At close: Mar 13, 2026

TPE:1720 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,0236,7896,2405,8514,604
Revenue Growth (YoY)
3.44%8.81%6.64%27.09%6.94%
Cost of Revenue
4,1143,8013,5143,3642,536
Gross Profit
2,9092,9892,7252,4882,068
Selling, General & Admin
1,2881,2931,2091,100948.47
Research & Development
260.36288.09266.27251.88241.79
Operating Expenses
1,5461,5921,4661,3691,191
Operating Income
1,3631,3971,2601,118876.83
Interest Expense
-8.45-15.07-25.42-18.78-7.25
Interest & Investment Income
29.0450.4876.8439.4524.99
Earnings From Equity Investments
-4.66-11.3641.5661.37-6.16
Currency Exchange Gain (Loss)
-86.855.62170.44-25.6
Other Non Operating Income (Expenses)
135.1551.0830.135.4477.66
EBT Excluding Unusual Items
1,5141,5581,3881,406940.47
Gain (Loss) on Sale of Investments
--0.675.531.361.46
Gain (Loss) on Sale of Assets
--5.471.27-7.7873.78
Asset Writedown
-----1.81
Other Unusual Items
--0.190.020.11-66.45
Pretax Income
1,5141,6271,4381,4001,014
Income Tax Expense
258.35333.05279.94246.31176.95
Earnings From Continuing Operations
1,2561,2941,1581,154836.8
Minority Interest in Earnings
-327.87-413.81-323.04-338.21-130.07
Net Income
927.66880.5834.89815.41706.73
Net Income to Common
927.66880.5834.89815.41706.73
Net Income Growth
5.36%5.46%2.39%15.38%34.83%
Shares Outstanding (Basic)
179179179179179
Shares Outstanding (Diluted)
179179179179179
Shares Change (YoY)
0.10%0.01%0.00%-0.02%0.02%
EPS (Basic)
5.194.934.674.563.95
EPS (Diluted)
5.184.924.674.563.95
EPS Growth
5.29%5.35%2.41%15.44%34.81%
Free Cash Flow
1,2781,098710.8331.78613.56
Free Cash Flow Per Share
7.136.143.970.183.43
Dividend Per Share
-2.8002.7002.5002.500
Dividend Growth
-3.70%8.00%-38.89%
Gross Margin
41.42%44.02%43.68%42.51%44.91%
Operating Margin
19.41%20.57%20.19%19.11%19.05%
Profit Margin
13.21%12.97%13.38%13.94%15.35%
Free Cash Flow Margin
18.19%16.18%11.39%0.54%13.33%
EBITDA
1,7971,7721,5791,3891,073
EBITDA Margin
25.58%26.09%25.30%23.74%23.31%
D&A For EBITDA
433.97375.06319.44270.67196.31
EBIT
1,3631,3971,2601,118876.83
EBIT Margin
19.41%20.57%20.19%19.11%19.05%
Effective Tax Rate
17.07%20.47%19.47%17.59%17.46%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.